Yi Zhao
![Yi Zhao Yi Zhao](https://til-therapies.com/wp-content/uploads/sites/262/2024/05/Yi-Zhao-speaker-150x150.png)
Company: Sino-Cell Biomed New!
Job title: Chief Technology Officer & Chief Executive Officer
Seminars:
Optimizing Manufacture Culture Conditions to Reduce Dependence on IL2 In Vivo 5:00 pm
Reduced IL-2 in culture system Target production time 16 days Significantly less IL-2 after TIL infusion and TCR data show TIL repopulation in vivoRead more
day: Conference Day One